If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBanco Santander Regulatory News (BNC)

Share Price Information for Banco Santander (BNC)

Share Price is delayed by 15 minutes
Get Live Data
1,056.00    22.00 (2.13%)
Bid:
1,060.00
Ask:
1,064.00
Spread: 4.00 (0.377%)
Market Cap: £151.30b
BNC Live PriceLast checked at - London Stock Exchange

Intraday Banco Santander Share Chart

Share capital increase

4 Jul 2017 07:00

RNS Number : 0001K
Banco Santander S.A.
03 July 2017
 

 

 

 

 

 

MATERIAL FACT

 

 

Following the material fact of 7 June 2017 (registration number 252,990), Banco Santander, S.A. ("Banco Santander" or the "Bank") informs that its executive committee, acting under the authorization granted to the board of directors by the general shareholders' meeting held on 7 April 2017 under item five of the agenda and the subsequent delegation of powers approved by the Bank's board of directors in favour of the abovementioned executive committee, has agreed to increase Banco Santander's share capital by a nominal amount of EUR 729,116,372.50 by issuing 1,458,232,745 new ordinary shares, of the same class and series as the shares currently outstanding, and with pre-emptive subscription rights for shareholders (the "Capital Increase" or the "Increase").

 

The issue of new shares will be carried out at their nominal value of fifty euro cents (0.50 €) plus an issue premium of EUR 4.35 per share, so that the total value of the issuance of new shares is EUR 4.85 per share and the total effective amount of the Capital Increase (including nominal value and issue premium) is EUR 7,072,428,813.25. The Increase aims to reinforce and optimize the Bank's equity structure to adequately cover the acquisition of 100% of Banco Popular Español, S.A.'s share capital.

 

Each outstanding share grants its holder a pre-emptive subscription right, and 10 pre-emptive subscription rights are required to subscribe 1 new share. Once the relevant prospectus has been registered with the Spanish Securities Market Commission ("CNMV"), the Increase will be officially communicated by publication in the Official Gazette of the Commercial Registry and, after that, the period to exercise pre-emptive subscription rights will commence, lasting 15 calendar days as from the day immediately following the publication date of the announcement. It is estimated that the pre-emptive subscription rights period commences on 6 July and ends on 20 July (both inclusive). Pre-emptive subscription rights are expected to be listed on the Spanish stock exchanges and the stock exchanges of Lisbon and Buenos Aires. Any pre-emptive subscription rights that are not exercised will automatically expire at the end of the pre-emptive subscription right subscription period.

 

Shareholders with pre-emptive subscription rights and investors or shareholders who acquire them in the market, may request to subscribe a number of additional shares besides those to which they are entitled by exercising their rights, if the Capital Increase is not fully subscribed in the pre-emptive subscription rights subscription period and as long as both investors and shareholders have exercised all their pre-emptive subscription rights. In addition, if requests for additional shares are insufficient to cover the Capital Increase, the remaining new shares may be discretionally allotted to investors.[1] The newly issued shares in the Capital Increase are expected to grant a share in the first interim dividend charged against the results of the 2017 financial year.

 

Banco Santander has entered into an underwriting agreement, for the entire Capital Increase, with a syndicate of credit entities, under which the Increase is fully underwritten. Banco Santander, Citigroup Global Markets Limited and UBS Limited will act as joint global coordinators of the Capital Increase.

 

The terms and conditions of the Capital Increase and the procedure to subscribe new shares in Spain, the United Kingdom, Portugal, Italy and Poland are set out in a prospectus to be registered with the CNMV. Once registered with the CNMV, the prospectus will be publicly available at the Bank's registered address and, in electronic format, in the web pages of the Bank (www.santander.com) and the CNMV (www.cnmv.es).

 

Boadilla del Monte (Madrid), 3 July, 2017

______________________________________________________________________

 

IMPORTANT INFORMATION

 

This document is not an informative prospectus but an informative communication and investors should not subscribe any new shares of Banco Santander, S.A. ("Banco Santander" or the "Bank") or purchase any pre-emptive subscription rights for new shares of the Bank's Capital Increase referred to in this document except on the basis of the information contained in the prospectus of the rights issue which Banco Santander will register with the Comisión Nacional del Mercado de Valores ("CNMV"). Once registered with the CNMV, the prospectus will be publicly available at the Bank's registered address and, in electronic format, in the web pages of the Bank (www.santander.com) and the CNMV (www.cnmv.es). The Bank expects to request the CNMV to passport the prospectus of the rights issue, once approved and registered, for the purposes of it being effective in the United Kingdom, Italy, Portugal and Poland.

 

This announcement does not constitute an offer to sell, or a solicitation of offers to subscribe, the pre-emptive subscription rights or the new shares of the share capital increase, in any jurisdiction in which such offer or solicitation is unlawful or, as the case may be, until the applicable requirements for those purposes have been met. The distribution of this announcement and/or the prospectus and/or the transfer of pre-emptive subscription rights and/or new shares into jurisdictions other than Spain, the United Kingdom, Italy, Portugal and Poland may be restricted by law. Persons who gain access to this announcement should be aware of and comply with any such restrictions. Any failure to comply with them may constitute a breach of the securities laws of any such jurisdiction.

 

This communication (i) must not be construed in any way to be a request to buy or to sell securities or any related financial instruments in Brazil, and (ii) must not be construed in any way to be a public offering of securities in Brazil. The Brazilian Securities Commission (Comissão de Valores Mobiliários) has not authorised the public offering of shares to which this communication refers nor of any securities related to such shares. Hence, the said shares cannot be offered to the public in Brazil.

 

The Bank has filed a registration statement (including a prospectus) with the SEC for the capital increase and the offering of new shares and subscription rights to which this communication relates. Before you invest, you should read the prospectus in that registration statement and other documents the Bank has filed with the SEC for more complete information about the issuer and this offering. You may get these documents for free by visiting EDGAR on the SEC Web site at www.sec.gov. Alternatively, you may obtain a copy of the prospectus from Citigroup by calling toll free 1-800-831-9146 or UBS by calling toll free 1-877-387-2275.

 

Authorisation for the public offering of the new Banco Santander shares and their admission to trading in the Buenos Aires stock exchange will be requested to the Argentine National Securities Commission. Once such authorisation is granted, a Subscription Announcement will be published in Argentina setting out the procedure and term to subscribe new shares in Argentina. The capital increase to which this announcement refers and the Argentine offering will have the same terms and conditions, save as otherwise provided in the relevant Subscription Announcement.

 


[1] The procedure for the subscription of the new shares may differ for investors who hold Banco Santander's shares in the different foreign stock exchanges in which the Bank's shares are listed.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCOKNDQKBKBNOK
Date   Source Headline
12th Nov 20211:05 pmRNSBuyback programme: transactions 5 Nov - 11 Nov
5th Nov 20211:02 pmRNSBuyback programme: transactions 29 Oct - 4 Nov
29th Oct 20211:04 pmRNSBuyback programme: transactions between 22&28 Oct
29th Oct 20217:00 amRNSSantander Mexico tender offer supplementary info
27th Oct 20217:00 amRNS3Q2021 results report & analyst presentation
27th Oct 20217:00 amRNS3rd Quarter 2021 Results - Press release
26th Oct 20213:14 pmRNS3rd Quarter Results announcement
22nd Oct 20211:06 pmRNSBuyback programme: transactions between 15&21 Oct
19th Oct 202110:55 amRNSForm 8.3 - Meggitt plc
15th Oct 20211:09 pmRNSBuyback programme: transactions between 6&14 Oct
6th Oct 20217:12 amRNSCommencement of a program to repurchase own shares
5th Oct 20219:39 amRNSForm 8.3 - Avast Plc
30th Sep 20213:22 pmRNSForm 8.3 - Avast Plc
30th Sep 20213:17 pmRNSForm 8.3 - Meggitt Plc
30th Sep 20213:16 pmRNSForm 8.3 - Meggitt Plc
30th Sep 20211:25 pmRNSHalf-yearly Financial Report
28th Sep 20215:55 pmRNSDividend Declaration
15th Sep 20215:50 pmRNSIssue of Debt
15th Sep 20211:16 pmRNSForm 8.3 - Sanne Group plc
15th Sep 20211:08 pmRNSForm 8.3 - Ultra Electronics Holdings plc
3rd Sep 20212:56 pmRNSForm 8.3 - NortonLifeLock Inc.
3rd Sep 20212:40 pmRNSForm 8.3 - Avast Plc
3rd Sep 20212:20 pmRNSForm 8.3 - Meggitt Plc
2nd Sep 20211:04 pmRNSOptional early redemption of Preferred Securities
24th Aug 20217:00 amRNSAgreement between SHUSA & SCUSA Holdings
3rd Aug 202112:13 pmRNSDirector/PDMR Shareholding
30th Jul 20215:13 pmRNSStress Test Results
30th Jul 202110:35 amRNSOptional early redemption ISIN XS1107291541
28th Jul 20217:00 amRNS1H2021 results report & analyst presentation
28th Jul 20217:00 amRNSFirst half 2021 results press release
27th Jul 20213:02 pmRNSNotice of First Half 2021 Results
15th Jul 20215:07 pmRNSAcquisition of Amherst Pierpont Presentation
15th Jul 20215:05 pmRNSSantander to acquire Amherst Pierpont
10th Jun 202112:11 pmRNSDirector/PDMR Shareholding
9th Jun 20217:00 amRNSSantander Mexico tender offer supplementary info
25th May 20217:00 amRNSSantander Mexico tender offer supplementary info
21st May 20218:43 amRNSForm 8.3 - RSA Insurance Group plc
7th May 20217:00 amRNSIssue of Preferred Tier 1 Securities CoCos
30th Apr 202112:03 pmRNSDirector/PDMR Shareholding
30th Apr 20218:04 amRNS2020 Banco Santander Annual Report
28th Apr 20217:00 amRNSFirst Quarter 2021 press release
28th Apr 20217:00 amRNSFirst Quarter 2021 Earnings Presentation
28th Apr 20217:00 amRNSFirst Quarter 2021 Financial Report
27th Apr 20213:06 pmRNSNotice of Results for the 1st Quarter 2021
20th Apr 202111:04 amRNSForm 8.3 - RSA Insurance Group
9th Apr 202112:53 pmRNSChange in the Group’s reportable segments
6th Apr 20211:51 pmRNSForm 8.3 - RSA Insurance Group Plc
26th Mar 20211:53 pmRNSAGM Resolutions
26th Mar 20217:00 amRNSSantander Mexico Tender Offer Presentation
26th Mar 20217:00 amRNSInformation on Santander Mexico, dividends, Board

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.